Panel A Panel B Panel C History SCC before Pain study

Slides:



Advertisements
Similar presentations
Figure 1.1 The observer in the truck sees the ball move in a vertical path when thrown upward. (b) The Earth observer views the path of the ball as a parabola.
Advertisements

Anal Cancer - Case 1  62 years old woman with 6 months history of anal pain  Clinically T 3 squamous cell carcinoma growing anteriorly  Which staging.
PIK3CA gene amplification in glioblastoma and squamous cell carcinoma (SCC) of the lung. PIK3CA gene amplification in glioblastoma and squamous cell carcinoma.
Copyright © 2009 American Medical Association. All rights reserved.
Part-time Student Survey
Epidermal Growth Factor Receptor Mutation in a Patient with Squamous Cell Carcinoma of the Lung: Who Should Be Tested Case Rep Oncol 2013;6:
Fig. 1. A case of squamous cell carcinomas of the lung, which presented as multiple tracheobronchial polyps in a 61-year-old male.A. Initial CT without.
Volume 105, Issue 3, Pages (March 1994)
Brett R. Barlow, BS, Ryan V. Marshall, BS, MS, John David Wofford, MD 
Well to moderately differentiated squamous cell carcinoma
Volume 3, Issue 6, Pages (November 2017)
Is Survey Cancer of the Lung Curable?
Keratoacanthoma Accompanied by Multiple Lung Squamous Cell Carcinomas Developing in a Renal Transplant Recipient Case Rep Dermatol 2014;6: DOI: /
A Rare Silent Killer: Right Atrial Metastasis of Thyroid Hürthle Cell Carcinoma Case Rep Oncol 2015;8: DOI: / Fig. 1. The patient.
CD47 expression for in situ and invasive cutaneous epithelial lesions
Nat. Rev. Urol. doi: /nrurol
Exposed hardware in a patient with invasive keratinocyte carcinoma
The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection.
Mannose-Binding Lectin Does Not Act as a Biomarker for the Progression of Preinvasive Lesions of Invasive Cervical Cancer Med Princ Pract - DOI: /
C D Coomassie stained gel PD:RNF4 KDa KDa
Genetic Profiling of BRAF Inhibitor–Induced Keratoacanthomas Reveals No Induction of MAP Kinase Pathway Expression  Rajan P. Kulkarni, Seema Plaisier,
Volume 150, Issue 1, Pages (July 2018)
Nicole M. Cassler, MD, Jason D. Marquart, MD, Corey A. Carter, MD 
Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients  O. Epaulard, C. Saint-Raymond,
Exploring the relationship between natural killer cells and cutaneous squamous cell carcinoma development  Muneeb Ilyas, BSc, Collin M. Costello, BS,
Skin Cancers Associated With Acquired Immunodeficiency Syndrome
Young H. Lim, Jonathan M. Fisher, Marcus W. Bosenberg, Keith A
On Molecular Classification of Bladder Cancer: Out of One, Many
Volume 1, Issue 1, Pages (January 2015)
Volume 86, Issue 1, Pages (July 2014)
Cohort Studies (and Skin Cancer) Never Come Alone
Volume 1, Issue 6, Pages (November 2015)
Best Practices in Lymph Node Mapping and Localization: Melanoma
Prognostic Factors Associated With Interventional Bronchoscopy in Lung Cancer  Nicolas Guibert, MD, Julien Mazieres, MD, PhD, Benoît Lepage, MD, Gavin.
Digital metastasis of tongue squamous cell carcinoma
Incidence trends for each human papillomavirus-related cancer-type among women in Norway 1953–2015. Incidence trends for each human papillomavirus-related.
Squamous-cell transformation in a patient with lung adenocarcinoma receiving erlotinib: Co-occurrence with T790M mutation  Diogo D.G. Bugano, Neda Kalhor,
XL888 Limits Vemurafenib-Induced Proliferative Skin Events by Suppressing Paradoxical MAPK Activation  Manali Phadke, Geoffrey T. Gibney, Carolyn J. Rich,
Epidermal Desmoglein 1 Expression Is Reduced in Kidney Transplant Recipients Compared with Immunocompetent Patients  Jodi L. Johnson, Paul Hoover, Borko.
Volume 4, Issue 10, Pages (November 2018)
Volume 3, Issue 6, Pages (November 2017)
Age does not influence early and late tumor-related outcome for bronchogenic carcinoma  Franziska Bernet, MD, Rudolf Brodbeck, MD, Marie-Olivier Guenin,
Mutational Analysis of BRAF Inhibitor–Associated Squamoproliferative Lesions  Britt Clynick, Tania Tabone, Kathryn Fuller, Wendy Erber, Katie Meehan, Michael.
Plasmacytoid dendritic cell involvement in the host response against keratoacanthoma  Ossama Abbas, MD, Lama Hussein, MD, Mazen Kurban, MD, Abdul-Ghani.
Recurrent and metastatic squamous cell carcinoma in lung transplant recipient on voriconazole: Lessons learned  Shali Zhang, MD, David C. Neujahr, MD,
Malignant transformation of a chronically infected implantable cardioverter-defibrillator pocket  Donna Kang, MD, Khuyen Do, MD, Jonathan Nattiv, MD,
Endocrine II.
Focus on nasopharyngeal carcinoma
Tissue Microarray Journal of Investigative Dermatology
Simon R. Junankar, Alexandra Eichten, Annegret Kramer, Karin E
Spectrum and progression of disease from condyloma to aggressive anogenital squamous cell carcinoma in 3 HIV-positive patients  Olaf Rodriguez, BS, Carrie.
Nader Aboul-Fettouh, BS, Rajiv I. Nijhawan, MD  JAAD Case Reports 
Squamous cell carcinomas of the skin responsive to erlotinib: 5 cases
Volume 5, Issue 3, Pages (March 2019)
Prognostic Value of Chromosomal Imbalances in Squamous Cell Carcinoma and Adenocarcinoma of the Lung  Bernhard C. Danner, MD, Timo Hellms, MD, Klaus Jung,
Stephanie Mlacker, MD, Urvashi Kaw, MD, Edward V. Maytin, MD, PhD 
Andrew D. Breithaupt, MD, David Beynet, MD, Teresa Soriano, MD 
Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy  Feng Wang, MD, Yuzhen Zheng, MD, Zhen Wang,
Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole  Edward W. Cowen, MD,
Serial biopsy samples taken from the patient in figs 1and 2, showing from left to right: acute myocarditis, healing myocarditis, dilated cardiomyopathy.

Comparison of the nADC value and CNR on T2-weighted images of 13 histologically confirmed brain lesions. Comparison of the nADC value and CNR on T2-weighted.
Comparison of tumor staging systems for cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia  Jacob J. Inda, MD, Brian F. Kabat,
In EBUS-TBNA smears scattered epithelioid cell granulomas (panels a and b) were seen along with occasional multinucleated giant cells ­(panels c and d).
Immune profiling of patient-derived organotypic tumor spheroids.
High genomic fidelity of SCLC PDX models derived from both CTCs and biopsies. High genomic fidelity of SCLC PDX models derived from both CTCs and biopsies.
Volume 98, Issue 1, Pages (July 1990)
Fig. 5 Spatial resolution of the optogenetic activation achieved with OLED microarrays. Spatial resolution of the optogenetic activation achieved with.
* OS >3yr with No Next Line * * * * *
Fig. 3 4n hybrids undergo bipolar and tripolar mitosis.
Presentation transcript:

Panel A Panel B Panel C History SCC before Pain study Original Pain study Pain follow-up study No SCC/KA 145 No SCC/KA 162 No SCC 197 SCC/KA 50 No SCC/KA 288 Missing 2 SCC/KA 123 SCC 91 No SCC/KA 17 SCC/KA 73 Missing 1 Missing 3 No SCC/KA 13 Fig S1. Schematic representation of the original SCOPE-ITSCC PAIN study (Panel B), history of SCC before the SCOPE-ITSCC PAIN study (Panel A) and new or subsequent SCC/KA during the cohort study (Panel C). During the follow-up study 50 SCC/KA developed in the 197 patients who had never had SCC before; 73 SCC/KA developed in the 91 patients who had SCC before the PAIN study, but not when a biopsy was taken for the original PAIN study; 21 SCC/KA developed in the 34 patients who did not have a history of SCC prior to the original PAIN study but presented with an SCC/KA at the start of the original PAIN study and 70 SCC/KA developed in the 88 patients who had a history of SCC before and a new SCC/KA during the PAIN study (left side of Panel C). The numbers indicate the number of patients in the different categories. SCC: squamous cell carcinoma; KA: keratoacanthoma. SCC/KA 21 No SCC 34 SCC/KA 122 No SCC/KA 31 SCC 88 SCC/KA 91 No SCC/KA 18 SCC/KA 70 Panel A Panel B Panel C